299 related articles for article (PubMed ID: 11938555)
1. [Advanced glycation end products (AGEs), free radicals and diabetes].
Gillery P
J Soc Biol; 2001; 195(4):387-90. PubMed ID: 11938555
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative stress and protein glycation in diabetes mellitus].
Gillery P
Ann Biol Clin (Paris); 2006; 64(4):309-14. PubMed ID: 16829472
[TBL] [Abstract][Full Text] [Related]
3. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
[TBL] [Abstract][Full Text] [Related]
4. [Effects of advanced glycation end products and its receptor on oxidative stress in diabetic wounds].
Niu YW; Miao MY; Dong W; Dong JY; Cao XZ; Lu SL
Zhonghua Shao Shang Za Zhi; 2012 Feb; 28(1):32-5. PubMed ID: 22490537
[TBL] [Abstract][Full Text] [Related]
5. [Glycation, glycoxidation and diabetes mellitus].
Boulanger E; Wautier JL; Dequiedt P; Schmidt AM
Nephrol Ther; 2006 Jan; 2 Suppl 1():S8-16. PubMed ID: 17378134
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical properties and clinical significance of protein glycation products].
Staniszewska M; Gamian A
Postepy Hig Med Dosw; 2003; 57(2):123-47. PubMed ID: 12866352
[TBL] [Abstract][Full Text] [Related]
7. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.
Aldini G; Vistoli G; Stefek M; Chondrogianni N; Grune T; Sereikaite J; Sadowska-Bartosz I; Bartosz G
Free Radic Res; 2013 Aug; 47 Suppl 1():93-137. PubMed ID: 23560617
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
Wu L; Ma L; Nicholson LF; Black PN
Respir Med; 2011 Mar; 105(3):329-36. PubMed ID: 21112201
[TBL] [Abstract][Full Text] [Related]
9. Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants.
Kovacic P; Somanathan R
J Recept Signal Transduct Res; 2011 Oct; 31(5):332-9. PubMed ID: 21929288
[TBL] [Abstract][Full Text] [Related]
10. [The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus].
Ksiazek K; Wiśniewska J
Przegl Lek; 2001; 58(10):915-8. PubMed ID: 11957818
[TBL] [Abstract][Full Text] [Related]
11. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
Lalla E; Lamster IB; Schmidt AM
Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
[TBL] [Abstract][Full Text] [Related]
12. Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway.
Lv X; Lv GH; Dai GY; Sun HM; Xu HQ
Chin J Nat Med; 2016 Nov; 14(11):844-855. PubMed ID: 27914528
[TBL] [Abstract][Full Text] [Related]
13. [Advanced glycosylation end products (AGE): new toxins?].
Boulanger E; Dequiedt P; Wautier JL
Nephrologie; 2002; 23(7):351-9. PubMed ID: 12500421
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
15. [Detection of carbonyl stress markers in the urine of diabetic patients].
Wittmann I; Wagner Z; Pótó L; Wagner L; Mazák I; Nagy J
Orv Hetil; 1999 Aug; 140(33):1841-5. PubMed ID: 10489784
[TBL] [Abstract][Full Text] [Related]
16. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and adipocyte biology: focus on the role of AGEs.
Boyer F; Vidot JB; Dubourg AG; Rondeau P; Essop MF; Bourdon E
Oxid Med Cell Longev; 2015; 2015():534873. PubMed ID: 25878764
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
Kalousová M; Zima T; Tesar V; Dusilová-Sulková S; Skrha J
Mutat Res; 2005 Nov; 579(1-2):37-46. PubMed ID: 16084533
[TBL] [Abstract][Full Text] [Related]
19. Glycation and lipid peroxidation in children and adolescents with type 1 diabetes mellitus with and without diabetic complications.
Kostolanská J; Jakus V; Barák L
J Pediatr Endocrinol Metab; 2009 Jul; 22(7):635-43. PubMed ID: 19774845
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
Wautier JL; Zoukourian C; Chappey O; Wautier MP; Guillausseau PJ; Cao R; Hori O; Stern D; Schmidt AM
J Clin Invest; 1996 Jan; 97(1):238-43. PubMed ID: 8550841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
